| Evaluate the Safety and Clinical Activity of HH2853 (NCT04390737) | Haihe Biopharma Co., Ltd. | 2020-09-08 |
| PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 (NCT04581915) | Wits Health Consortium (Pty) Ltd | 2020-09-08 |
| Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma (NCT04340843) | National Cancer Institute (NCI) | 2020-09-08 |
| Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis (NCT04312594) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2020-09-08 |
| Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840 (NCT04573309) | Alexion Pharmaceuticals, Inc. | 2020-09-07 |
| Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants (NCT04830371) | EuBiologics Co.,Ltd | 2020-09-07 |
| Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML (NCT03597321) | Institut Paoli-Calmettes | 2020-09-07 |
| to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis (NCT05162937) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2020-09-07 |
| GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis (NCT03865927) | University of Alabama at Birmingham | 2020-09-07 |
| Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial (NCT04075331) | University of Leicester | 2020-09-07 |
| PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy (NCT04494009) | Asan Medical Center | 2020-09-07 |
| AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With Hypoparathyroidism (NCT05239221) | Alexion Pharmaceuticals, Inc. | 2020-09-07 |
| Propranolol Adjuvant Treatment of Bladder Cancer (NCT04493489) | Central South University | 2020-09-06 |
| Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI) (NCT04295538) | AbbVie | 2020-09-06 |
| Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients (NCT04610502) | Caja Costarricense de Seguro Social | 2020-09-06 |
| Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT04267913) | SWOG Cancer Research Network | 2020-09-05 |
| Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Glucocorticoid Treatment for No-Reflow in STEMI (NCT06552442) | Amosov National Institute of Cardiovascular Surgery | 2020-09-05 |
| Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma (NCT04401800) | BeiGene | 2020-09-04 |
| Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug (NCT04534114) | Bayer | 2020-09-04 |
| A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer (NCT04838548) | Shanghai Miracogen Inc. | 2020-09-04 |
| Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase (NCT04195347) | St. Jude Children's Research Hospital | 2020-09-04 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer) (NCT04436744) | Hoffmann-La Roche | 2020-09-04 |
| A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT04240002) | Astellas Pharma Global Development, Inc. | 2020-09-04 |
| Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04550442) | M.D. Anderson Cancer Center | 2020-09-04 |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC) (NCT04385290) | Technische Universität Dresden | 2020-09-04 |
| A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab (NCT04493424) | Boehringer Ingelheim | 2020-09-04 |
| Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia (NCT04578210) | Instituto de Investigación Hospital Universitario La Paz | 2020-09-04 |
| A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence (NCT04512053) | Taiho Pharmaceutical Co., Ltd. | 2020-09-04 |
| Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 (NCT04527471) | Verona Pharma Inc | 2020-09-04 |
| Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19) (NCT04596839) | Dr. Md. Alimur Reza | 2020-09-04 |
| A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer (NCT04474470) | TyrNovo Ltd. | 2020-09-03 |
| Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH (NCT04251065) | Fondazione Italiana Linfomi - ETS | 2020-09-03 |
| A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT04442022) | Karyopharm Therapeutics Inc | 2020-09-03 |
| Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis (NCT04826432) | Gustave Roussy, Cancer Campus, Grand Paris | 2020-09-03 |
| Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19 (NCT05200754) | Carsten Müller-Tidow | 2020-09-03 |
| Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome (NCT04355689) | Nacuity Pharmaceuticals, Inc. | 2020-09-03 |
| A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors (NCT05593094) | Hoffmann-La Roche | 2020-09-03 |
| The Sahlgrenska Anti-VEGF Study (NCT04101877) | Vastra Gotaland Region | 2020-09-03 |
| HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma (NCT04353375) | Hutchmed | 2020-09-03 |
| Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain (NCT04455633) | Lexicon Pharmaceuticals | 2020-09-03 |
| A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma (NCT04088500) | Bristol-Myers Squibb | 2020-09-03 |
| Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older (NCT04537208) | Sanofi Pasteur, a Sanofi Company | 2020-09-03 |
| Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19 (NCT04532931) | Shin Poong Pharmaceutical Co. Ltd. | 2020-09-03 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (NCT04365101) | Celularity Incorporated | 2020-09-02 |
| N-Acetylcysteine Protection Against Radiation Induced Cellular Damage (NCT04154982) | Centro Cardiologico Monzino | 2020-09-02 |
| Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) (NCT04332744) | MedSIR | 2020-09-02 |
| Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome (NCT04528108) | Children's Hospital of Fudan University | 2020-09-02 |
| Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: (NCT03861702) | Nelson Yee | 2020-09-02 |
| Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation (NCT04463004) | Virginia Commonwealth University | 2020-09-02 |
| REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors (NCT04526106) | Elevar Therapeutics | 2020-09-02 |
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer (NCT04544111) | Memorial Sloan Kettering Cancer Center | 2020-09-02 |
| Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) (NCT04392128) | Institut de cancérologie Strasbourg Europe | 2020-09-02 |
| Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab (NCT04401995) | Diwakar Davar | 2020-09-02 |
| A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) (NCT04504032) | Gates Medical Research Institute | 2020-09-02 |
| Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder (NCT04337827) | Deepa Jagadeesh | 2020-09-02 |
| Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients (NCT04362722) | Philogen S.p.A. | 2020-09-02 |
| Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients (NCT04440982) | Lumicell, Inc. | 2020-09-01 |
| Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy (NCT04541277) | Chinese PLA General Hospital | 2020-09-01 |
| Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis (NCT04348890) | ReveraGen BioPharma, Inc. | 2020-09-01 |
| Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes (NCT03396484) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2020-09-01 |
| Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation (NCT03513458) | University of North Carolina, Chapel Hill | 2020-09-01 |
| Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19. (NCT04395170) | Lifefactors Zona Franca, SAS | 2020-09-01 |
| Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma (NCT04396860) | National Cancer Institute (NCI) | 2020-09-01 |
| Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer (NCT04526470) | Seoul National University Bundang Hospital | 2020-09-01 |
| A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia (NCT04455581) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-01 |
| IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS. (NCT04357613) | Versailles Hospital | 2020-09-01 |
| Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer (NCT04486287) | Tianjin Medical University Second Hospital | 2020-09-01 |
| Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia (NCT04527354) | PHARMENTERPRISES LLC | 2020-09-01 |
| Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid (NCT04326959) | PT. Prodia Stem Cell Indonesia | 2020-09-01 |
| Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors (NCT04260009) | Takeda | 2020-09-01 |
| 18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer (NCT04487847) | Radboud University Medical Center | 2020-09-01 |
| Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma (NCT04462809) | Hospices Civils de Lyon | 2020-09-01 |
| Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19 (NCT04323228) | King Saud University | 2020-09-01 |
| Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo (NCT04539067) | Minia University | 2020-09-01 |
| The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder (NCT04593563) | Maryland Oncology Hematology, PA | 2020-09-01 |
| A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma (NCT04533321) | National University Hospital, Singapore | 2020-09-01 |
| Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia (NCT04453384) | Nantes University Hospital | 2020-09-01 |
| Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment (NCT04699214) | Yong Chen | 2020-09-01 |
| A Study of JR-171 in Patients With Mucopolysaccharidosis I (NCT04227600) | JCR Pharmaceuticals Co., Ltd. | 2020-09-01 |
| 18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease (NCT04502303) | Peking Union Medical College Hospital | 2020-09-01 |
| Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS) (NCT04717037) | King Abdullah International Medical Research Center | 2020-09-01 |
| Psilocybin in Depression Resistant to Standard Treatments (NCT04959253) | King's College London | 2020-09-01 |
| Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI) (NCT02776488) | University of California, Los Angeles | 2020-09-01 |
| Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT04548271) | Sun Yat-sen University | 2020-09-01 |
| Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (NCT04644250) | Wei Ren | 2020-09-01 |
| The Combined Use of PRP with Lipoaspirate And/or Bone Marrow Aspirate in Osteoarthritis (NCT03984461) | Dr. Grant M. Pagdin | 2020-09-01 |
| Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (NCT04542161) | Weill Medical College of Cornell University | 2020-09-01 |
| Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients (NCT04954014) | Maimónides Biomedical Research Institute of Córdoba | 2020-09-01 |
| Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC (NCT04238169) | Xinqiao Hospital of Chongqing | 2020-09-01 |
| Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM) (NCT04400019) | University of Malaga | 2020-09-01 |
| Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP (NCT04917679) | Qilu Hospital of Shandong University | 2020-09-01 |
| Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19 (NCT04470297) | Associação Fundo de Incentivo à Pesquisa | 2020-09-01 |
| HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM (NCT04547621) | Huashan Hospital | 2020-09-01 |
| Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture (NCT05018637) | Inbo Han | 2020-09-01 |
| Systemic Erythropoietin Injection in Patients Having Optic Atrophy (NCT04680143) | Alexandria University | 2020-09-01 |
| Interferon Lambda Therapy for COVID-19 (NCT04388709) | Icahn School of Medicine at Mount Sinai | 2020-09-01 |
| Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 (NCT04371965) | Poitiers University Hospital | 2020-09-01 |
| Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors (NCT04569916) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2020-09-01 |
| Treatment of SARS Caused by COVID-19 With Ruxolitinib (NCT04334044) | Grupo Cooperativo de Hemopatías Malignas | 2020-09-01 |
| CSL324 in COVID-19 (NCT04519424) | CSL Behring | 2020-09-01 |